On Monday, Protagonist Therapeutics, Inc. (NASDAQ:PTGX) and Takeda Pharmaceutical Co Ltd (NYSE:TAK) released topline results for the Phase 3 VERIFY study of rusfertide for polycythemia vera.

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker. Weber – who was briefly chief operating officer of Takeda ...

January 30, 2025 Drugmaker Takeda's CEO Weber to step down, raises profit forecast Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm ...

What is the current and next Wuthering Waves banner? Otherwise known as Convenes, WuWa banners run on a three-week rotation, which doesn’t give you much time to decide which characters to pull ...

What are the Zenless Zone Zero banners? If you’re looking to expand your roster of playable agents, then wishing on banners is your best bet. These digital gacha machines form the basis of ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 million in new financing to ...

Control Freak stars Kelly Marie Tran as Val, who is a motivational speaker. Tran is known for her roles in films like Star Wars: Episode IX – The Rise of Skywalker and Star Wars: Episode VIII – The ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Newsweek and Plant-A Insights Group are partnering for the third year to determine America's Greatest Workplaces for Women 2025. "America's Greatest Workplaces for Women 2025" recognizes the ...